BIORESTORATIVE THERAPIES ($BRTX) posted quarterly earnings results for Q4 2025 on Thursday, March 26th. The company reported earnings of -$0.32 per share, beating estimates of -$0.38 by $0.06. The company also reported revenue of $20,000, missing estimates of $153,000 by $-133,000.
Stock price change since market close: +2.3%
You can see Quiver Quantitative's $BRTX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
BIORESTORATIVE THERAPIES Hedge Fund Activity
We have seen 6 institutional investors add shares of BIORESTORATIVE THERAPIES stock to their portfolio, and 13 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CITADEL ADVISORS LLC removed 77,012 shares (-72.5%) from their portfolio in Q4 2025, for an estimated $90,489
- DRW SECURITIES, LLC added 46,665 shares (+inf%) to their portfolio in Q4 2025, for an estimated $54,831
- STONEX GROUP INC. removed 37,450 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $44,003
- MORGAN STANLEY removed 35,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $50,750
- VIRTU FINANCIAL LLC removed 24,351 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $28,612
- STATE STREET CORP added 12,000 shares (+58.7%) to their portfolio in Q4 2025, for an estimated $14,100
- TWO SIGMA SECURITIES, LLC added 11,777 shares (+inf%) to their portfolio in Q4 2025, for an estimated $13,837
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
